Sun Pharma, India's largest drugmaker, has designated Aalok Shanghvi as Chief Operating Officer. Aalok, the son of promoter Dilip Shanghvi,...

Sun Pharma Board has appointed Aalok Shanghvi as a whole-time director for a five-year term beginning June 1, 2023. Shanghvi, the son of Su...

Uractiv is the leading brand in its category in Romania, trusted by consumers for more than 10 years, Sun Pharma said in a statement.

Under the terms of the licensing agreement, Hikma will be responsible for the registration and commercialisation of the product in all MENA...

Sun Pharma reported total revenue from operations at Rs 8,259 crore, or 16 per cent higher.

“Sun paid 6,00,000 euros as commissions to Aalok Shanghvi in 2011/12 and nobody raised a question.”

The process of the acquisition of 85.1 per cent of JSC Biosintez has been completed today," Sun Pharma said in a filing to BSE.

Mahadik, 48, was senior vice president - global head of human resources business, transformation, IT and operations of Philips.

The deal, announced in February this year, would see Shanghvi acquiring at least 23 per cent stake in Suzlon which has been grappling with ...

Our objective would be to complete the integration in the shortest possible span of time so that we address all the uncertainties that peop...

Kal Sundaram, who is CEO of North America business for Sun Pharma will lead the North American business for both the organisations.

Most executives from Ranbaxy's earlier team have already left the company in past one year.

This weekend, Shanghvi announced a Rs 1,400-crore investment to pick up 23% stake in ailing renewable energy company Suzlon through DSA.

Dilip Shanghvi's brother-in-law Sudhir Valia will provide Rs 4,000 crore, which the debt-hit Suzlon will use to meet its working capital ne...

Shanghvi started his entrepreneurial dreams with a loan of Rs 10,000 from his father. It’s that same instinct that’s needed at Ranbaxy now,...

His staff call him India's most aggressive promoter whose calm demeanour shadows his killer instincts when it comes to splurging on riskies...

Stock market wealth of children of top honchos at country's listed cos rose to over Rs 14,000 cr in 2013, led by those holding shares of IT...